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Background
The development of new and potent anti-HIV com-
pounds has become almost obligatory for the scientific
community due to rapid emergence of drug resistant
mutations. In pursuance of developing new anti-HIV
molecules, we herein report the design, synthesis and
anti-HIV properties of a series of potent arylsulfonila-
mide derivatives as NNRTIs.
Methods
Development of arylsulfonilamides as NNRTIs involved
both the computational and synthetic methods. On the
basis of extensive docking experiments, ten promising
compounds out of 55 initially taken were synthesized
using green protocols and their in vitro anti-HIV activity
assessed in TZM bl cells by luciferase assay and reverse
transcriptase (RT) inhibition assay against wild type
HIV-1 RT.
Results
The compounds showed very promising in silico results
as reflected by their lower ΔG values-high binding affi-
nity, significant scoring functions high RT- ligand stabili-
zation energy and close interatomic contacts through
strong H-bonds with Lys103, His235, Tyr318, Lys101 and
Val179; pi-pi interaction with Tyr181 and pi-cation inter-
action through Lys101, which all together predicted high
EC50 values. However, the molecules showed unimpres-
sive inhibitory action against HIV-1 under in vitro condi-
tions. The encouraging part of this study was that these
compounds behaved as NNRTIs as per our expectations,
on the basis of results obtained during HIV-RT assay.
Conclusions
In the present study, it has been observed that promis-
ing in silico results are not always corroborated by the
desired in vitro results. Nevertheless, it is a part and
parcel of drug discovery process, where successful drug
development is nearly a hard nut to crack.
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